SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-332506
Filing Date
2021-11-17
Accepted
2021-11-17 16:27:57
Documents
13
Period of Report
2021-11-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d239253d8k.htm   iXBRL 8-K 29331
2 EX-99.1 d239253dex991.htm EX-99.1 6106
  Complete submission text file 0001193125-21-332506.txt   162434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bttx-20211110.xsd EX-101.SCH 2916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20211110_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20211110_pre.xml EX-101.PRE 11421
6 EXTRACTED XBRL INSTANCE DOCUMENT d239253d8k_htm.xml XML 3384
Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036
Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1028
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 211420907
SIC: 8000 Services-Health Services